Docoh
Loading...

THMO ThermoGenesis

ThermoGenesis Holdings, Inc. engages in the research, development, commercialization, and marketing of automated cell processing technologies for the cell and gene therapy field. It operates through the Device and Clinical Development segment. The Device segment includes the development and commercialization of automated technologies for cell-based therapeutics and bioprocessing. The Clinical Development segment utilizes autologous stem cell-based therpeutics. The company was founded by Philip H. Coelho in 1986 and is headquartered in Rancho Cordova, CA.

Company profile

Ticker
THMO
Exchange
CEO
Xiaochun Xu
Employees
Incorporated
Location
Fiscal year end
Former names
CESCA THERAPEUTICS INC., THERM0GENESIS CORP, THERMOGENESIS CORP
SEC CIK
IRS number
943018487

THMO stock data

(
)

Investment data

Data from SEC filings
Securities sold
Number of investors

Calendar

17 Mar 21
13 Apr 21
31 Dec 21
Quarter (USD)
Dec 20 Sep 20 Jun 20 Mar 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
Dec 20 Dec 19 Dec 18 Jun 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Cash burn rate (estimated) Burn method: Change in cash Burn method: Operating income/loss Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 7.16M 7.16M 7.16M 7.16M 7.16M 7.16M
Cash burn (monthly) (positive/no burn) (positive/no burn) 472K 741.33K 844.67K 1.2M
Cash used (since last report) n/a n/a 1.62M 2.55M 2.91M 4.13M
Cash remaining n/a n/a 5.54M 4.61M 4.25M 3.03M
Runway (months of cash) n/a n/a 11.7 6.2 5.0 2.5

Beta Read what these cash burn values mean

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
4 Jun 20 Donaghy Debra Stock Option Common Stock Grant Aquire A No No 5.94 10,000 59.4K 10,000
4 Jun 20 Westgate Mark Stock Option Common Stock Grant Aquire A No No 5.94 10,000 59.4K 10,000
4 Jun 20 Joseph Thomis Stock Option Common Stock Grant Aquire A No No 5.94 10,000 59.4K 10,000
4 Jun 20 Medford Russell M Stock Option Common Stock Grant Aquire A No No 5.94 10,000 59.4K 10,000
4 Jun 20 Cauble Jeffery Stock Option Common Stock Grant Aquire A No No 5.94 40,000 237.6K 40,000

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

13F holders
Current Prev Q Change
Total holders 0 15 EXIT
Opened positions 0 4 EXIT
Closed positions 15 6 +150.0%
Increased positions 0 2 EXIT
Reduced positions 0 2 EXIT
13F shares
Current Prev Q Change
Total value 0 2.3M EXIT
Total shares 0 243.93K EXIT
Total puts 0 0
Total calls 0 0
Total put/call ratio
Largest owners
Shares Value Change
Renaissance Technologies 0 $0
Largest transactions
Shares Bought/sold Change
BLK Blackrock 0 -94.27K EXIT
Vanguard 0 -56.17K EXIT
Diametric Capital 0 -38.26K EXIT
Prelude Capital Management 0 -25.79K EXIT
Geode Capital Management 0 -22.41K EXIT
BAC Bank Of America 0 -3.2K EXIT
MS Morgan Stanley 0 -2.59K EXIT
Freestone Capital 0 -550 EXIT
WFC Wells Fargo & Co. 0 -282 EXIT
AdvisorNet Financial 0 -206 EXIT
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. freshman Avg
New words: accuracy, Aid, Alex, analyzed, Azar, BioHit, brand, cap, collateral, Comerica, Commissioner, contest, contradictory, counterparty, debit, diagnosing, disposition, EUA, FDC, Governor, Gurugram, Hefei, Hefer, HHS, IRC, lieu, mathematical, methodology, mortgage, Newsom, NOL, obsolete, outweigh, Paycheck, PPP, preceding, rank, RDO, SBA, Secretary, spending, staffing, supernatant, switch, threat, unapproved, unconsolidated, understated, voluntarily, wait, winding
Removed: accelerate, accepting, addressed, alleged, arrangement, assist, bodily, borne, building, cancer, cardiology, cardiovascular, CEO, Cesca, CFO, challenge, Chinese, chronic, codified, CODM, complaint, concentrate, constituted, Council, coupled, cumulative, dealing, deferral, dermal, discretionary, disposal, documented, dramatically, ease, employed, enterprise, ERP, expanded, expanding, exposure, final, flow, freely, freezing, function, fundamental, GCP, geared, GLP, Golden, harvest, headcount, IEC, implementation, improved, informed, initiation, involuntary, IRB, jointly, largely, leader, leadership, leaving, leverage, Meditech, million, Ministry, novacord, orthopedic, output, participant, partnership, phase, population, practical, practice, preferred, presenting, proven, recovery, reducing, reduction, regularly, reimburse, remained, sample, solution, successive, target, tissue, Totipotent, transplantation, treat, utilizing, vascular, vested, viability, viable